Admedus (ASX:AHZ) to begin first in-human aortic valve replacement trial

" Admedus (ASX:AHZ) to begin first in-human aortic valve replacement trial

Admedus (AHZ) has received approval for the first in-human surgical aortic valve replacement (SAVR) trial of its ADAPT single-piece 3D aortic valve.
ImpediMed (ASX:IPD) reports increased revenue for December quarter

" ImpediMed (ASX:IPD) reports increased revenue for December quarter

Medical software technology company ImpediMed (IPD) has reported increased revenue for the December 2019 quarter.
MyFiziq (ASX:MYQ) races to partner with U.S. fitness brand

" MyFiziq (ASX:MYQ) races to partner with U.S. fitness brand

MyFiziq (MYQ) has signed a binding term sheet with Bearn, the owner and operator of an “earn while you burn” fitness app.
Creso Pharma (ASX:CPH)  reaches 3 million sale milestone for Anibidiol

" Creso Pharma (ASX:CPH) reaches 3 million sale milestone for Anibidiol

Creso Pharma (CPH) has now sold over three million Anibidiol granule sachets since the products launch in 2017.
Skin Elements (ASX:SKN) to raise $1M through five-for-nine entitlement offer

" Skin Elements (ASX:SKN) to raise $1M through five-for-nine entitlement offer

Skincare specialist Skin Elements (SKN) is raising $1 million through a five-for-nine entitlement offer to expand its Soleo Organics and PapayaActivs range.
THC Global (ASX:THC) enters product supply agreement with MGC Pharma (ASX:MXC)

" THC Global (ASX:THC) enters product supply agreement with MGC Pharma (ASX:MXC)

THC Global (THC) has signed a supply agreement with MGC Pharmaceuticals (MXC) for its medicinal cannabis products.
HeraMED (ASX:HMD) accesses unique pregnancy database to strengthen OrionAI

" HeraMED (ASX:HMD) accesses unique pregnancy database to strengthen OrionAI

HeraMED (HMD) has received approximately 90,000 pregnancy monitoring records from the Mayo Clinic as part of a collaboration agreement.
Jatenergy (ASX:JAT) secures three year distribution agreement with Ocker Products

" G Medical Innovations (ASX:GMV) gets Taiwan FDA approval for Prizma

G Medical Innovations’ (GMV) Prizma medical device has been granted regulatory approval by the Taiwan Food and Drug Administration (FDA).
G Medical (ASX:GMV) one step closer to launching in China

" G Medical (ASX:GMV) one step closer to launching in China

G Medical Innovations (GMV) has completed the required trials for National Medical Products Administrations (NMPA) tick of approval.
MedAdvisor (ASX:MDR) signs second U.S. agreement with major company

" MedAdvisor (ASX:MDR) signs second U.S. agreement with major company

MedAdvisor (MDR) has signed its second U.S. agreement to provide medication education programs for a top 10 global pharmaceutical company.